Rapid Therapeutic Science Laboratories, Inc. Quarterly Interest Expense in USD from Q2 2017 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Rapid Therapeutic Science Laboratories, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2017 to Q2 2023.
  • Rapid Therapeutic Science Laboratories, Inc. Interest Expense for the quarter ending June 30, 2023 was $60.8K, a 92.1% decline year-over-year.
  • Rapid Therapeutic Science Laboratories, Inc. Interest Expense for the twelve months ending June 30, 2023 was $589K, a 78.9% decline year-over-year.
  • Rapid Therapeutic Science Laboratories, Inc. annual Interest Expense for 2022 was $1.9M, a 43.2% increase from 2021.
  • Rapid Therapeutic Science Laboratories, Inc. annual Interest Expense for 2021 was $1.32M, a 2182% increase from 2020.
  • Rapid Therapeutic Science Laboratories, Inc. annual Interest Expense for 2020 was $58K, a 69.7% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $589K $60.8K -$705K -92.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.29M $111K -$602K -84.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $1.9M $70.6K -$578K -89.1% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 $2.47M $346K -$312K -47.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.79M $766K +$762K +23037% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $2.02M $713K +$700K +5070% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $1.32M $649K +$694K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $630K $658K +$641K +3819% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$11.4K $3.31K -$19.3K -85.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $7.92K $13.8K -$50.1K -78.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $58K -$45.3K -$80.1K -230% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 $138K $16.8K -$30K -64.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $168K $22.6K -$23.5K -51% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $192K $63.9K +$18.1K +39.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $173K $34.8K -$10.9K -23.9% Oct 1, 2019 Dec 31, 2019 10-Q 2020-03-31
Q3 2019 $184K $46.8K +$960 +2.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $183K $46.1K +$2.93K +6.79% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $181K $45.8K +$17.2K +60.1% Jan 1, 2019 Mar 31, 2019 10-K 2020-06-29
Q4 2018 $163K $45.8K +$45.8K Oct 1, 2018 Dec 31, 2018 10-Q 2020-03-31
Q3 2018 $118K $45.8K +$45.8K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $71.8K $43.2K +$43.2K Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-26
Q1 2018 $28.6K $28.6K Jan 1, 2018 Mar 31, 2018 10-K 2019-07-09
Q4 2017 $0 Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2019-01-15
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2019-01-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.